Title of article
Group B streptococcal disease in UK and Irish infants younger than 90 days
Author/Authors
Paul T. Heath، نويسنده , , Gail Balfour، نويسنده , , Abbie M Weisner، نويسنده , , Androulla Efstratiou، نويسنده , , Theresa L Lamagni، نويسنده , , Helen Tighe، نويسنده , , Liam AF OʹConnell، نويسنده , , Mary Cafferkey، نويسنده , , Neville Q. Verlander، نويسنده , , Angus Nicoll، نويسنده , , A Christine McCartney and on behalf of the PHLS GBS Working Group، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
3
From page
292
To page
294
Abstract
The incidence, morbidity, and mortality of group B streptococcal disease in the UK and Republic of Ireland are largely unknown. Between Feb 1, 2000, and Feb 28, 2001, we identified cases of invasive group B streptococcal disease in infants younger than 90 days through surveillance involving paediatricians, microbiologists, and parents. 568 cases were identified, equivalent to a total incidence of 0•72 per 1000 live-births (95% CI 0•66–0•78); the incidence for early-onset disease (n=377) was 0•48 per 1000 (0•43–0•53), and for late-onset disease (n=191) was 0•24 per 1000 (0•21–0•28). Risk factors were identifiable for 218 (58%) cases of early-onset disease. 53 infants died (overall 9•7%). We have established the minimum current burden of group B streptococcal disease in UK and Irish infants. This information will assist in the formulation of guidelines for prevention of this disease.
Journal title
The Lancet
Serial Year
2004
Journal title
The Lancet
Record number
560282
Link To Document